title: Response to the publication: EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer.
authors.affiliation: Hospital Clinic, ARIBAU 161, Pral. 1a, Barcelona 08036, Spain. gascon@clinic.ub.es
authors.forename: Pere
authors.initials: P
authors.lastname: Gascón
authors.forename: Heinz
authors.initials: H
authors.lastname: Ludwig
mesh_terms: D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000627:therapeutic use*; D006397:Hematinics / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins
chemical_list: D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa